BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33637051)

  • 21. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania.
    Voiculescu M; Iliescu L; Ionescu C; Micu L; Ismail G; Zilisteanu D; Radasan A; Micu G; Pertache I
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):43-8. PubMed ID: 20361074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus epidemiology in Central-West Tunisia: a population-based cross-sectional study.
    Bettaieb J; Chouikha A; Khedhiri M; Kharroubi G; Badreddine M; Bel Hadj Hmida N; Gharbi A; Hammemi W; Sadraoui A; Ben Yahia A; Meddeb Z; Ben Salah A; Triki H
    Arch Virol; 2019 Sep; 164(9):2243-2253. PubMed ID: 31179516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus seroprevalence and prevalence of chronic infection in the adult population in Ireland: a study of residual sera, April 2014 to February 2016.
    Garvey P; O'Grady B; Franzoni G; Bolger M; Irwin Crosby K; Connell J; Burke D; De Gascun C; Thornton L
    Euro Surveill; 2017 Jul; 22(30):. PubMed ID: 28797323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey.
    Nafeh MA; Medhat A; Shehata M; Mikhail NN; Swifee Y; Abdel-Hamid M; Watts S; Fix AD; Strickland GT; Anwar W; Sallam I
    Am J Trop Med Hyg; 2000; 63(5-6):236-41. PubMed ID: 11421370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study.
    Kileng H; Gutteberg T; Goll R; Paulssen EJ
    BMC Infect Dis; 2019 Feb; 19(1):189. PubMed ID: 30808290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors.
    Elghouzzi MH; Bouchardeau F; Pillonel J; Boiret E; Tirtaine C; Barlet V; Moncharmont P; Maisonneuve P; du Puy-Montbrun MC; Lyon-Caen D; Couroucé AM
    Vox Sang; 2000; 79(3):138-44. PubMed ID: 11111231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia.
    Woldegiorgis AE; Erku W; Medhin G; Berhe N; Legesse M
    PLoS One; 2019; 14(12):e0226890. PubMed ID: 31887192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus infection among pregnant women in Slovenia: study on 31,849 samples obtained in four screening rounds during 1999, 2003, 2009 and 2013.
    Kopilović B; Poljak M; Seme K; Klavs I
    Euro Surveill; 2015 Jun; 20(22):21144. PubMed ID: 26062646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.
    Iversen J; Dore GJ; Catlett B; Cunningham P; Grebely J; Maher L
    J Hepatol; 2019 Jan; 70(1):33-39. PubMed ID: 30367897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C seroprevalence and correlation between viral load and viral genotype among primary care clients in Mexico.
    Burguete-García AI; Conde-González CJ; Jiménez-Méndez R; Juárez-Díaz Y; Meda-Monzón E; Torres-Poveda K; Madrid-Marina V
    Salud Publica Mex; 2011; 53 Suppl 1():S7-12. PubMed ID: 21877076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus (HCV) prevalence estimation in the adult general population in Belgium : a meta-analysis.
    Muyldermans G; Bielen R; Botterman R; Bourgeois S; Colle I; Deressa B; Devolder G; Horsmans Y; Hutse V; Lanthier N; Lasser L; Platteau S; Robaeys G; Suin V; Verhelst X; Van Vlierberghe H; Van Baelen L
    Acta Gastroenterol Belg; 2019; 82(4):479-485. PubMed ID: 31950802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey.
    Weill-Barillet L; Pillonel J; Semaille C; Léon L; Le Strat Y; Pascal X; Barin F; Jauffret-Roustide M
    Rev Epidemiol Sante Publique; 2016 Sep; 64(4):301-12. PubMed ID: 26904917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroprevalence of hepatitis C and correlates of seropositivity among men who have sex with men in Vancouver, Canada: a cross-sectional survey.
    Wong J; Moore D; Kanters S; Buxton J; Robert W; Gustafson R; Hogg R; Ogunnaike-Cooke S; Wong T; Gilbert M;
    Sex Transm Infect; 2015 Sep; 91(6):430-3. PubMed ID: 25872512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of hepatitis C virus in the general population of northwest Tanzania.
    Tess BH; Levin A; Brubaker G; Shao J; Drummond JE; Alter HJ; O'Brien TR
    Am J Trop Med Hyg; 2000 Jan; 62(1):138-41. PubMed ID: 10761739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clustering of hepatitis C virus antibody positivity within households and communities in Punjab, India.
    Trickey A; Sood A; Midha V; Thompson W; Vellozzi C; Shadaker S; Surlikar V; Kanchi S; Vickerman P; May MT; Averhoff F
    Epidemiol Infect; 2019 Oct; 147():e283. PubMed ID: 31587676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus seropositivity and the risk factors for transmission among blood donors in some selected centers in Lagos State, Southwest Nigeria.
    Damola AB; Adeniji JA; Bakarey AS
    J Immunoassay Immunochem; 2019; 40(5):528-539. PubMed ID: 31378189
    [No Abstract]   [Full Text] [Related]  

  • 38. Seroprevalence, risk factors and genotype distribution for Hepatitis C infection: A study from rural hospital in Maharashtra.
    Patil SR; Datkhile KD; Ghorpade MV; Patil SS; Kakade SV
    Indian J Med Microbiol; 2017; 35(4):563-567. PubMed ID: 29405150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of HBV and HCV infections, Bhutan, 2017: Progress and next steps.
    Tshering N; Dhakal GP; Wangchuk U; Wangdi S; Khandu L; Pelden S; Nogareda F; Patel MK; Hutin YJF; Wannemuehler K; Rewari BB; Wangchuk S
    BMC Infect Dis; 2020 Jul; 20(1):485. PubMed ID: 32641006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.
    Hartleb M; Gutkowski K; Zejda JE; Chudek J; Więcek A
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1288-95. PubMed ID: 22864260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.